Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Ellen Sparger
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer
Keywords STAT3 cyclic STAT3 decoy head and neck cancer oral cancer STAT3 inhibitor clinical trial feline oral cancer Get full text access Log in, subscribe or purchase for full access. References 1. Zou, S. ∙ Tong, Q. ∙ Liu, B. ... Targeting STAT3 in Cancer Immunotherapy Mol. Cancer. 2020; 19:145 2. Johnson, D.E. ∙ O'Keefe, R.A. ∙ Grandis, J.R. Targeting the IL-6/JAK/STAT3 signalling axis in cancer Nat. Rev. Clin. Oncol. 2018; 15:234-248 3. Kortylewski, M. ∙ Yu, H.
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer
|
By Jennifer R. Grandis, Katherine A. Skorupski, Ning Cheng, Zhibin Cui, Hua Li, Liam C Woerner, Jovanka Gencel-Augusto, Yan Zeng, Neil E. Bhola, Kelly Blum, Mi-Ok Kim, Daniel York, Robert B. Rebhun, Hong Chang, Adam B. Olshen, Ellen Sparger, Daniel Johnson, Jamie V. Shiah, Malabika Sen, Natalia F. Murad
|
Cell Press
Verified
A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphoma
1. Introduction The typical canine malignant lymphoma patient presents with generalized lymphadenopathy with or without other clinical signs, but far from always this is the situation in the clinic. Malignant lymphoma can be found in many anatomical locations and with varying nonspecific symptoms.
Clinical utility of liquid biopsy in canine oral malignant melanoma using cell-free DNA
1. Introduction Canine oral malignant melanoma is an extremely aggressive tumor with a poor prognosis. Early surgical removal is required for long-term survival, with survival time reported to be ≥ 500 days for dogs with stage I tumors (< 2 cm diameter tumor) (1). Although the metastatic rate at diagnosis is 12.9%, local and distant metastases have been reported in ~70–95% of advanced dogs (2, 3).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ellen
Contact Ellen, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack